Lennox-Gastaut Syndrome (LGS) is a rare and severe form of childhood-onset epilepsy, characterized by multiple treatment-resistant seizure types and a high burden of comorbidities, including ...

This Saturday, April 26, 2025, the Lennox-Gastaut Syndrome (LGS) Foundation will be Stepping Together for a Breakthrough with families, friends, and communities around the world at their 10th Annual ...

About the LGS Foundation The Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS.

Most living with Lennox-Gastaut syndrome have some “impaired intellectual functioning or information processing, along with developmental delays and behavioral disturbances,” according to NINDS.

Lennox-Gastaut syndrome is a severe form of epilepsy that usually manifests in early childhood, according to the National Institute of Neurological Disorders and Stroke.

Evidence-based recommendations on fenfluramine (Fintepla) for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over. Last reviewed: 26 March 2025 Next review: This ...

Lennox-Gastaut Syndrome Lennox-Gastaut syndrome is a chronic, treatment-resistant form of epilepsy that typically starts before the age of 8 years. It is characterised by a distinct ...

Fenfluramine has been recommended by the National Institute for Health and Care Excellence for patients aged two and over with Lennox-Gastaut syndrome - a rare and severe form of epilepsy that is ...

Hope for children with severe form of epilepsy as NHS rolls out new drug Fenfluramine has been recommended by Nice for patients aged two and over with Lennox-Gastaut syndrome.

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, Baylor Genetics and collaborating institutions provided ...

These posters highlight groundbreaking work resulting from collaborations with both Longboard Pharmaceuticals and UCB, focusing on advancing understanding of sleep disturbances in individuals with ...